News
GLP-1 medications and menopause: What women need to know
2+ hour, 29+ min ago (701+ words) Home " Lifestyle " Health GLP-1 weight-loss medications are transforming how midlife women manage their weight " but a growing number of experts warn they come with hidden risks for women in perimenopause and menopause. Picture: i Stock GLP-1 receptor agonist medications, the…...
Local GLP-1 user loses 105 pounds, suffers few side effects
28+ min ago (452+ words) ROCHESTER, N. Y. "The use of GLP-1 medications for weight loss has skyrocketed, but there are side effects. One woman is sharing her experience with the medication and her weight loss success story. "I had high cholesterol, high blood pressure, sleep apnea....
CVS brings back coverage for Lilly's obesity drug Zepbound
1+ hour, 38+ min ago (347+ words) May 28 (Reuters) " CVS Health will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option and also begin coverage for "the drugmaker's newly approved obesity pill, Foundayo. CVS' Caremark, one of "the…...
France to be first country in Europe to reimburse weight-loss drugs
2+ hour, 45+ min ago (306+ words) France will start to reimburse weight-loss drugs such as Wegovy and Mounjaro starting 15 June, French Health Minister St'phanie Rist announced on Thursday. With this move, France becomes the first country in Europe to cover the costs of these types of…...
GLP-1 Weight Loss Drugs May Reduce Risk of Cancer Progression, According to Promising New Study
59+ min ago (505+ words) New research suggests the most popular weight-loss drugs on the market may be able do much more than help people lose weight. As reported on Thursday's AM Update, a promising new study from the Cleveland Clinic found GLP-1 drugs " including…...
France becomes first EU country to reimburse anti-obesity drugs, minister says
2+ hour, 38+ min ago (421+ words) May 28 (Reuters) - France will reimburse the cost of weight-loss drugs prescribed toseverely obese "patients from mid-June in a first for a European Union country, Health "Minister Stephanie Rist said on Thursday. Novo Nordisk's Wegovy and Eli Lilly's Mounjaro medications have…...
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care
38+ min ago (1287+ words) May 28, 2026, 13: 00 ET Phase 3 ACHIEVE results showed Foundayo, an oral GLP-1 taken without food or water restrictions, outperformed oral semaglutide and dapagliflozin in type 2 diabetes, reinforcing its potential to redefine oral incretin therapy New analyses of the ATTAIN program highlight Foundayo's…...
Beer Belly or Silent Killer? New Research Links Visceral Fat to a Higher Risk of Heart Attacks - AOL
3+ day, 2+ min ago (111+ words) What changes feel most realistic for reducing visceral fat in everyday life, and which habits seem the hardest to break? Hidden Sugars in "Healthy" Energy Drinks Are Destroying Men's Teeth " Dentists Warn of Acid Erosion 7 "Healthy" Comfort Foods That Are…...
Warning over online pharmacies claiming to be linked to Grimsby's hospital
5+ hour, 40+ min ago (202+ words) Grimsby Live NHS Humber Health Partnership said 'we do not operate any online pharmaceutical companies, even if they are claiming to be based at our hospitals' "We're concerned people are parting with their money for medicines that do not appear,…...
MTVA: No Evidence for Changes in Cardiovascular Parameters in Phase 1 Trial of DA-1726
2+ hour, 45+ min ago (150+ words) READ THE FULL MTVA RESEARCH REPORT Treatment with DA-1726 Shows No Evidence of Cardiovascular Changes Thus far, DA-1726 has had a favorable tolerability profile, as shown in the following table. Gastrointestinal adverse events (AEs) have been mostly mild-to-moderate in severity…...